Folgen
Eleonora Molesti
Eleonora Molesti
Scientist at Vismederi Research
Bestätigte E-Mail-Adresse bei vismederiresearch.com
Titel
Zitiert von
Zitiert von
Jahr
Antigenic drift in H5N1 avian influenza virus in poultry is driven by mutations in major antigenic sites of the hemagglutinin molecule analogous to those for human influenza virus
G Cattoli, A Milani, N Temperton, B Zecchin, A Buratin, E Molesti, MM Aly, ...
Journal of virology 85 (17), 8718-8724, 2011
1452011
Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry
J Long, E Wright, E Molesti, N Temperton, W Barclay
F1000Research 4, 2015
862015
Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples
L Mazzini, D Martinuzzi, I Hyseni, L Benincasa, E Molesti, E Casa, ...
Journal of Immunological Methods 489, 112937, 2021
832021
Mutations in haemagglutinin that affect receptor binding and pH stability increase replication of a PR8 influenza virus with H5 HA in the upper respiratory tract of ferrets and …
H Shelton, KL Roberts, E Molesti, N Temperton, WS Barclay
Journal of General Virology 94 (6), 1220-1229, 2013
732013
Characterisation of SARS-CoV-2 lentiviral pseudotypes and correlation between pseudotype-based neutralisation assays and live virus-based micro neutralisation assays
I Hyseni, E Molesti, L Benincasa, P Piu, E Casa, NJ Temperton, A Manenti, ...
Viruses 12 (9), 1011, 2020
672020
Adjuvant-free immunization with hemagglutinin-Fc fusion proteins as an approach to influenza vaccines
S Loureiro, J Ren, P Phapugrangkul, CA Colaco, CR Bailey, H Shelton, ...
Journal of virology 85 (6), 3010-3014, 2011
632011
The human Transmembrane Protease Serine 2 is necessary for the production of Group 2 influenza A virus pseudotypes
F Ferrara, E Molesti, E Böttcher-Friebertshäuser, G Cattoli, D Corti, ...
Journal of molecular and genetic medicine: an international journal of …, 2013
532013
Improved adjuvanting of seasonal influenza vaccines: Preclinical studies of MVA‐NP+ M 1 coadministration with inactivated influenza vaccine
CE Mullarkey, A Boyd, A van Laarhoven, EA Lefevre, B Veronica Carr, ...
European journal of immunology 43 (7), 1940-1952, 2013
462013
Multiplex evaluation of influenza neutralizing antibodies with potential applicability to in-field serological studies
E Molesti, E Wright, C Terregino, R Rahman, G Cattoli, NJ Temperton
Journal of immunology research 2014, 2014
422014
The use of equine influenza pseudotypes for serological screening
S Scott, E Molesti, N Temperton, F Ferrara, E Böttcher-Friebertshäuser, ...
Journal of molecular and genetic medicine: an international journal of …, 2012
302012
An optimized method for the production using PEI, titration and neutralization of SARS-CoV spike luciferase pseudotypes
G Carnell, K Grehan, F Ferrara, E Molesti, N Temperton
Bio-protocol 7 (16), e2514-e2514, 2017
272017
Comparative serological assays for the study of H5 and H7 avian influenza viruses
E Molesti, A Milani, C Terregino, G Cattoli, NJ Temperton
Influenza Research and Treatment 2013, 2013
262013
The production and development of H7 Influenza virus pseudotypes for the study of humoral responses against avian viruses
E Molesti, G Cattoli, F Ferrara, E Böttcher-Friebertshäuser, C Terregino, ...
Journal of molecular and genetic medicine: an international journal of …, 2013
262013
Intra-laboratory evaluation of luminescence based high-throughput serum bactericidal assay (L-SBA) to determine bactericidal activity of human sera against Shigella
O Rossi, E Molesti, A Saul, C Giannelli, F Micoli, F Necchi
High-throughput 9 (2), 14, 2020
222020
Antibody avidity and neutralizing response against SARS-CoV-2 Omicron variant after infection or vaccination
F Dapporto, S Marchi, M Leonardi, P Piu, P Lovreglio, N Decaro, ...
Journal of Immunology Research 2022, 2022
152022
The theory and practice of the viral dose in neutralization assay: Insights on SARS-CoV-2 “doublethink” effect
A Manenti, E Molesti, M Maggetti, A Torelli, G Lapini, E Montomoli
Journal of Virological Methods 297, 114261, 2021
132021
Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations
CM Trombetta, G Piccini, G Pierleoni, M Leonardi, F Dapporto, S Marchi, ...
Communications biology 5 (1), 903, 2022
122022
Discordant correlation between serological assays observed when measuring heterosubtypic responses against avian influenza H5 and H7 viruses in unexposed individuals
E Molesti, F Ferrara, G Lapini, E Montomoli, N Temperton
BioMed research international 2014, 2014
122014
The application of pseudotypes to influenza pandemic preparedness
F Ferrara, E Molesti, N Temperton
Future Virology 10 (6), 731-749, 2015
92015
SARS-CoV-2 seroconversion and pregnancy outcomes in a population of pregnant women recruited in Milan, Italy, between April 2020 and October 2020
V Accurti, B Gambitta, S Iodice, A Manenti, S Boito, F Dapporto, ...
International Journal of Environmental Research and Public Health 19 (24), 16720, 2022
42022
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20